Boeing´s (NYSE: BA) board of directors has elected Robert A. Bradway as a new member, where he will serve on the board´s audit and finance committees, the company said.
Bradway is chairman and CEO of Amgen, a biotechnology company. He joined Amgen in 2006 and has served the company in senior finance and operations strategy roles, including chief financial officer and chief operating officer. He joined Amgen from Morgan Stanley where he had responsibility for the firm´s banking department and corporate finance activities in Europe.
Boeing is a large aerospace company and manufacturer of commercial jetliners and defense, space and security systems. The company supports airlines and US and allied government customers in 150 countries.